Objective: The pandemic condition has hampered the health system because of government efforts to limit the spread of the coronavirus disease-2019 (COVID-19). These restrictions can affect the management of children with Type 1 diabetes mellitus (T1DM). We aimed to assess the correlation between patient adherence and glycemic control during early pandemic. Material and Methods: T1DM patients who regularly control to Pediatric Endocrine Outpatient Clinic of Dr. Soetomo Hospital, aged 4-18 years old and whose parents were willing to jjoin this study were included. The sample was randomly collected by phone from July 2nd to 28th, 2020 (during early pandemic). We used the Diabetes Management Questionnaire (DMQ) (parents-reported method for children aged 13 years). The correlation between variables was analyzed by using Pearson correlation test. Results: Thirty patients were included in our study (mean age: 11.70±3.49 years old; the mean DMQ score: 56.33±11.30). The mean (±SD) HbA1c level was 11.35 (1.95) %. The DMQ score consists of 4 sectors, including adherence to insulin use, diet management, physical activity and glycemic monitoring, the means of patient's score vs maximum score as followed (10.00 vs 10.00), (24.83 vs 40.00), (6.87 vs 15), (18.25 vs 35). Unfortunately, the correlation analysis on patient's adherence and HbA1c was not significant (r=-0.231; p=0.164). Conclusion: The correlation between patient's adherence and HbA1c was not significant. Meanwhile, adherence to insulin showed maximal score during early COVID-19 pandemic.
Keywords: T1DM; COVID-19; children; adherence; glycemic control
Amaç: Pandemik koşullar hükümetin koronavirüs hastalığı2019 (COVID-19)'un yayılımını sınırlamak için girdiği çabalar nedeniyle sağlık sistemini aksatmıştır. Bu kısıtlamalar Tip 1 diabetes mellituslu (T1DM) çocukların yönetimini etkileyebilir. Erken COVID- 19 pandemisi sürecinde hasta uyumu ile glisemik kontrol, glikolize hemoglobin (HbA1c) arasındaki korelasyonu değerlendirmeyi amaçladık. Gereç ve Yöntemler: Yaşları 4 ile 18 arasında değişen, Dr. Soetomo Hastanesi Pediyatrik Endokrin Polkliniğine düzenli olarak kontrole gelen ve ebeveynleri çalışmaya katılmaya istekli olan T1DM tanılı çocuklar çalışmaya alındı. Verileri 2-28 Temmuz 2020 tarihleri arasında (erken pandemi dönemi) telefon görüşmesi yoluyla rastgele örneklem yöntemi ile çevrimiçi olarak topladık. Diyabet Yönetimi Anketini (DYA) (13 yaş çocukların kendilerinin doldurduğu bir anket) kullandık. Değişkenler arasındaki korelasyon Pearson korelasyon testi kullanılarak incelendi. Bulgular: Çalışmamıza 30 hasta alındı (ortalama yaş 11,70±3,49 yıl; ortalama DYA skoru 56,33±11,30). DYA insülin kullanımına uyum, diyet yönetimi, fiziksel aktivite ve glisemik takip olmak üzere 4 bölümden oluşmaktadır. Hasta skorlarının ortalaması vs DYA anketinin her bölümünün maksimum skoru şöyleydi: 10,00 vs 10,00), (24,83 vs 40,00), (6,87 vs 15), (18,25 vs 35). Her DYA bölümünün HbA1c ile korelasyonu şöyleydi: sırasıyla (r=0,026; p=0,893), (r=-0,058; p=0,761), (r=-0,004; p=0,982), (r=0,007; p=0,973). Ortalama (±SS) HbA1c düzeyi 11,35 (1,95) % idi. Maalesef, hasta uyumu ile HbA1cnin korelasyon analizi anlamlı değildi (r=0,231; p=0,164). Sonuç: Çalışmamızda hasta uyumu ile HbA1c arasındaki korelasyon anlamlı değildi. Bu arada, insüline uyum erken COVID-19 pandemisi döneminde maksimum skoru aldı.
Anahtar Kelimeler: T1DM; COVID-19; çocuklar; uyum; glisemik kontrol
- Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365-88. [Crossref] [PubMed]
- Nugraha B, Wahyuni LK, Laswati H, Kusumastuti P, Tulaar AB, Gutenbrunner C. COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia. Acta Med Indones. 2020;52(3):299-305. [PubMed]
- Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020;127:104354. [Crossref] [PubMed] [PMC]
- O'Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, et al. COVID-19 hospitalization in adults with type 1 diabetes: results from the T1D exchange multicenter surveillance study. J Clin Endocrinol Metab. 2021;106(2):e936-42. [Crossref] [PubMed] [PMC]
- d'Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, et al. Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract. 2020;168:108372. [Crossref] [PubMed] [PMC]
- Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95-104. [Crossref] [PubMed] [PMC]
- Delameter AM. Improving patient adherence. Clinical Diabetes. 2006;24(2):71-7. [Crossref]
- Chowdhury S, Goswami S. COVID-19 and type 1 diabetes: dealing with the difficult duo. Int J Diabetes Dev Ctries. 2020:1-6. [Crossref] [PubMed] [PMC]
- Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021;44(2):526-32. [Crossref] [PubMed] [PMC]
- Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab Syndr. 2020;14(5):1213-6. [Crossref] [PubMed] [PMC]
- Mehta SN, Nansel TR, Volkening LK, Butler DA, Haynie DL, Laffel LM. Validation of a contemporary adherence measure for children with Type 1 diabetes: the Diabetes Management Questionnaire. Diabet Med. 2015;32(9): 1232-8. [Crossref] [PubMed] [PMC]
- Rochmah N, Faizi M, Hisbiyah Y, Triastuti IW, Wicaksono G, Endaryanto A, et al. Quality of life differences in pre- and post-educational treatment in type 1 diabetes mellitus during COVID-19. Diabetes Metab Syndr Obes. 2021;14:2905-11. [Crossref] [PubMed] [PMC]
- Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-24. [Crossref] [PubMed]
- Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171-9. [Crossref] [PubMed]
- Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004; 38(9):1357-62. [Crossref] [PubMed]
- Lai Ying C, Shah NM. Adherence to insulin treatment in children with type i diabetes mellitus at a hospital in Malaysia. Asian Journal of Pharmaceutical and Clinical Research. 2017;10(11):356-61. [Crossref]
- Seckold R, Howley P, King BR, Bell K, Smith A, Smart CE. Dietary intake and eating patterns of young children with type 1 diabetes achieving glycemic targets. BMJ Open Diabetes Res Care. 2019;7(1):e000663. [Crossref] [PubMed] [PMC]
- MacMillan F, Kirk A, Mutrie N, Matthews L, Robertson K, Saunders DH. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention design, and efficacy. Pediatr Diabetes. 2014; 15(3):175-89. [Crossref] [PubMed]
- Gökşen D, Atik Altınok Y, Ozen S, Demir G, Darcan S. Effects of carbohydrate counting method on metabolic control in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2014;6(2):74-8. [Crossref] [PubMed] [PMC]
- Döğer E, Bozbulut R, Soysal Acar AŞ, Ercan Ş, Kılınç Uğurlu A, Akbaş ED, et al. Effect of telehealth system on glycemic control in children and adolescents with type 1 diabetes. J Clin Res Pediatr Endocrinol. 2019;11(1):70-5. [Crossref] [PubMed] [PMC]
- Tao J, Gao L, Liu Q, Dong K, Huang J, Peng X, et al. Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic. Diabetes Res Clin Pract. 2020;170:108514. [Crossref] [PubMed] [PMC]
- Pulungan AB, Fadiana G, Annisa D. Type 1 diabetes mellitus in children. Clin Pediatr Endocrinol. 2021;30(1):11-8. [Crossref] [PubMed] [PMC]
- Beraki Å, Magnuson A, Särnblad S, Åman J, Samuelsson U. Increase in physical activity is associated with lower HbA1c levels in children and adolescents with type 1 diabetes: results from a cross-sectional study based on the Swedish pediatric diabetes quality registry (SWEDIABKIDS). Diabetes Res Clin Pract. 2014;105(1):119-25. [Crossref] [PubMed]
- Carral F, Gutiérrez JV, Ayala Mdel C, García G, Aguilar M. Intense physical activity is associated with better metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2013;101(1):45-9. [Crossref] [PubMed]
- Gandhi K, Vu BK, Eshtehardi SS, Wasserman RM, Hillliard ME. Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice. Diabetes Manag (Lond). 2015;5(6):485-98. [Crossref] [PubMed] [PMC]
- Gomes KF, Semzezem C, Batista R, Fukui RT, Santos AS, Correia MR, et al. Importance of zinc transporter 8 autoantibody in the diagnosis of type 1 diabetes in Latin Americans. Sci Rep. 2017;7(1):207. [Crossref] [PubMed] [PMC]
- Bhatty A, Baig S, Fawwad A, Rubab ZE, Shahid MA, Waris N. Association of zinc transporter-8 autoantibody (ZnT8A) with type 1 diabetes mellitus. Cureus. 2020;12(3):e7263. [Crossref] [PubMed] [PMC]
- Braga de Souza AC, Felício JS, Koury CC, Neto JF, Miléo KB, Santos FM, et al; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG). Health-related quality of life in people with type 1 diabetes mellitus: data from the Brazilian Type 1 Diabetes Study Group. Health Qual Life Outcomes. 2015;13:204. [Crossref] [PubMed] [PMC]
- Park YJ, Yoo SA, Kim WU. Role of endoplasmic reticulum stress in rheumatoid arthritis pathogenesis. J Korean Med Sci. 2014;29(1): 2-11. [Crossref] [PubMed] [PMC]
- Kiani AK, John P, Bhatti A, Zia A, Shahid G, Akhtar P, et al. Association of 32 type 1 diabetes risk loci in Pakistani patients. Diabetes Res Clin Pract. 2015;108(1):137-42. [Crossref] [PubMed]
- Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009;52(9):1881-8. [Crossref] [PubMed]
- Mattana TC, Santos AS, Fukui RT, Mainardi-Novo DT, Costa VS, Santos RF, et al. CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort. Mediators Inflamm. 2014;2014:694948. [Crossref] [PubMed] [PMC]
.: Process List